Ayala Pharmaceuticals Inc (fka ADXS)

[fbg0316]

Dew is right. O'Connor did a lot of damage to the company's reputation. Just look at the exodus of many of our largest holders and 40% vote against the latest comp proposal and comp committee. Rarely do public companies see this kind if opposition, which is why we have seen the stock collapsed and O'Connor stepped down. Lombardo is turning things around but it takes time. 2018 will be a much better year and the latest reduction in short interest is evidence, and there will be more covering in January for those waiting to pay lower taxes.